BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2009
View Archived Issues
Shanghai Institute Materia Medica claims PPARgamma agonists for polycystic kidney disease
Read More
Banyu presents Wee1 kinase inhibitors as oncolytic compounds
Read More
Boehringer Ingelheim discloses novel cannabinoid CB2 receptor agonists as analgesics
Read More
GlaxoSmithKline claims novel stearoyl-CoA desaturase inhibitors for the treatment of obesity
Read More
Novel orexin receptor antagonists for sleep disorders patented by Merck & Co.
Read More
10-year results show long-term effects of gene therapy for SCID-X1
Read More
AMA1-C1/Alhydrogel vaccine fails to reach primary endpoint in phase II trial in Malian children
Read More
DNAI gene therapy corrects dysfunction seen in primary ciliary dyskinesia
Read More
QLT reports positive primary analysis results from phase II RADICAL study in wet AMD
Read More
WELCOME results show effects of certolizumab pegol in Crohn's disease patients failing infliximab
Read More
Inovio Biomedical merges with VGX Pharmaceuticals
Read More
Raptor initiates dosing in phase IIb clinical trial of DR Cysteamine in nephropathic cystinosis
Read More
Clinical Data presents positive results from second phase III vilazodone trial
Read More
Snapshots: Exelixis oncolytic compounds discussed at ASCO annual meeting
Read More
Multiple clinical data presentations on carfilzomib given at ASCO
Read More
Clinical results with salirasib reported for lung, pancreatic cancer studies
Read More
PolyMedix receives DTRA grant to develop antibiotic compounds for biowarfare pathogens
Read More
Novartis and Nordic complete enrollment in phase III study of oral calcitonin in osteoarthritis
Read More
Takeda revises development strategy for alogliptin and alogliptin/pioglitazone
Read More
Wellcome Trust awards EUR 5.15 million grant to NVGH to develop typhoid vaccine
Read More
FDA places partial clinical hold on Genmab's zalutumumab
Read More
Peregrine reports positive results from three phase II clinical trials of bavituximab in cancer
Read More
German regulator clears Silence Therapeutics' CTA for phase I study of ATU-027 in cancer
Read More
FDA accepts GE Healthcare's NDA for DaTSCAN for priority review
Read More
Kamada submits BLA for intravenous AAT for alpha-1 antitrypsin deficiency
Read More
FDA denies Advaxis' request for orphan drug designation for ADXS-11-001 in invasive cervical cancer
Read More
FDA issues complete response letter to ViroPharma regarding sBLA for Cinryze in HAE
Read More
Novavax and NIH to evaluate a virus-like particle vaccine for influenza A (H1N1)
Read More
AstraZeneca and Abbott submit NDA for Certriad for mixed dyslipidemia
Read More